Radiomarcati

Radiomarcati is an Italian term used in science to describe substances or samples that have been labeled with a radioactive isotope for tracing, quantification, or imaging. The process is radiomarcatura (radiolabeling). Radiomarcati can refer to molecules, pharmaceutical compounds, nucleic acids, proteins, or biological samples that carry detectable radioactivity.

Applications include pharmacokinetic studies, metabolic tracking, receptor binding analysis, and autoradiography. In medical imaging, radiomarcati compounds are used as radiopharmaceuticals for diagnostic imaging (for example, technetium-99m labeled compounds and fluorine-18 labeled molecules for PET). Radiomarcati also support basic research by measuring turnover, localization, or uptake of substances in cells or tissues. In some cases these labeled compounds are used therapeutically (radiopharmaceutical therapy) by delivering cytotoxic radiation to target tissues.

Common isotopes used are beta, alpha, or gamma emitters, including tritium (3H), carbon-14 (14C), phosphorus-32 (32P), sulfur-35 (35S), iodine-125 (125I), iodine-131 (131I), technetium-99m (99mTc), fluorine-18 (18F), and carbon-11 (11C), among others. The choice depends on the half-life, radiation type, and detection method required for the specific study.

Detection and analysis rely on scintillation counting, gamma spectroscopy, autoradiography, gamma cameras, SPECT, or PET imaging. The use of radiomarcati requires appropriate radiation safety controls, regulatory approvals, trained personnel, and proper waste disposal due to radiation exposure. In Italian scientific literature, radiomarcati is used as a direct description of labeled materials; in English texts the equivalent terms are radiolabeled or radiolabeled compounds.